- Home
- CPAC vs FDMT Comparison
CPAC vs FDMT Comparison
Compare CPAC & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPAC
- FDMT
- Stock Information
- Founded
- CPAC 1949
- FDMT 2013
- Country
- CPAC Peru
- FDMT United States
- Employees
- CPAC N/A
- FDMT N/A
- Industry
- CPAC Building Materials
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- CPAC Industrials
- FDMT Health Care
- Exchange
- CPAC Nasdaq
- FDMT Nasdaq
- Market Cap
- CPAC 495.3M
- FDMT 420.7M
- IPO Year
- CPAC 2012
- FDMT 2020
- Fundamental
- Price
- CPAC $5.91
- FDMT $6.32
- Analyst Decision
- CPAC Sell
- FDMT Buy
- Analyst Count
- CPAC 1
- FDMT 10
- Target Price
- CPAC $6.00
- FDMT $42.44
- AVG Volume (30 Days)
- CPAC 15.2K
- FDMT 724.9K
- Earning Date
- CPAC 10-29-2024
- FDMT 11-13-2024
- Dividend Yield
- CPAC 8.96%
- FDMT N/A
- EPS Growth
- CPAC 7.38
- FDMT N/A
- EPS
- CPAC 0.12
- FDMT N/A
- Revenue
- CPAC $527,798,215.00
- FDMT $17,000.00
- Revenue This Year
- CPAC N/A
- FDMT N/A
- Revenue Next Year
- CPAC N/A
- FDMT $87.55
- P/E Ratio
- CPAC $10.04
- FDMT N/A
- Revenue Growth
- CPAC N/A
- FDMT N/A
- 52 Week Low
- CPAC $4.82
- FDMT $6.32
- 52 Week High
- CPAC $6.65
- FDMT $36.25
- Technical
- Relative Strength Index (RSI)
- CPAC 47.57
- FDMT 30.56
- Support Level
- CPAC $5.80
- FDMT $6.42
- Resistance Level
- CPAC $6.10
- FDMT $7.58
- Average True Range (ATR)
- CPAC 0.16
- FDMT 0.43
- MACD
- CPAC 0.02
- FDMT -0.05
- Stochastic Oscillator
- CPAC 58.70
- FDMT 2.42
About CPAC Cementos Pacasmayo S.A.A. (Each representing five)
Cementos Pacasmayo SAA is a Peruvian cement company that primarily produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are primarily used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.